Veterinary Medicine Information website

Clavoral 250/62.5 mg tablet for dogs and cats (strength 250 mg amoxicillin + 62.5 mg)

Not authorised
  • Potassium clavulanate
  • Amoxicillin trihydrate
Download as PDF

Product identification

Medicine name:
Clavoral 250/62.5 mg tablet for dogs and cats (strength 250 mg amoxicillin + 62.5 mg)
Active substance:
  • Potassium clavulanate
  • Amoxicillin trihydrate
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Potassium clavulanate
    74.45
    milligram(s)
    /
    1.00
    Tablet
  • Amoxicillin trihydrate
    287.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01CR02
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Surrendered
Authorised in:
  • Netherlands
Package description:
  • Carton containing 5 aluminium/aluminium blister strips each strip with 4 tablets corresponding to 20 tablets per carton.
  • Carton containing 5 aluminium/aluminium blister strips each strip with 2 tablets corresponding to 10 tablets per carton.
  • Carton containing 25 aluminium/aluminium blister strips each strip with 4 tablets corresponding to 100 tablets per carton
  • Carton containing 25 aluminium/aluminium blister strips each strip with 10 tablets corresponding to 250 tablets per carton
  • Carton containing 10 aluminium/aluminium blister strips each strip with 10 tablets corresponding to 100 tablets per carton
  • Carton containing 1 aluminium/aluminium blister strip with 10 tablets corresponding to 10 tablets per carton.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Hybrid application (Article 13(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Ast Farma B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Lelypharma B.V.
Responsible authority:
  • Medicines Evaluation Board
Authorisation number:
  • REG NL 10086
Date of authorisation status change:
Reference member state:
  • Netherlands
Procedure number:
  • NL/V/0149/002

Documents

Combined File of all Documents

English (PDF)
Published on: 27/10/2025
Download
Dutch (PDF)
Published on: 19/01/2022
Download